Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1503

1.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007 Jun;29(6 Pt 1):1254-70. Review.

PMID:
18036388
[PubMed - indexed for MEDLINE]
2.

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

Ilag LL, Kerr L, Malone JK, Tan MH.

Clin Ther. 2007;29 Spec No:1254-70. Review.

PMID:
18046926
[PubMed - indexed for MEDLINE]
3.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
[PubMed - indexed for MEDLINE]
4.

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

Clin Ther. 2008 Nov;30(11):1976-87. doi: 10.1016/j.clinthera.2008.11.001.

PMID:
19108786
[PubMed - indexed for MEDLINE]
5.
6.

Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.

Rolla AR, Rakel RE.

Clin Ther. 2005 Aug;27(8):1113-25. Review.

PMID:
16199240
[PubMed - indexed for MEDLINE]
7.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
[PubMed - indexed for MEDLINE]
8.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
[PubMed - indexed for MEDLINE]
9.

A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.

Jacober SJ, Scism-Bacon JL, Zagar AJ.

Diabetes Obes Metab. 2006 Jul;8(4):448-55.

PMID:
16776752
[PubMed - indexed for MEDLINE]
10.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
[PubMed - indexed for MEDLINE]
11.

Premixed insulin analogues for the treatment of diabetes mellitus.

Garber AJ.

Drugs. 2006;66(1):31-49. Review.

PMID:
16398567
[PubMed - indexed for MEDLINE]
12.

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.

Liebl A, Prager R, Binz K, Kaiser M, Bergenstal R, Gallwitz B; PREFER Study Group.

Diabetes Obes Metab. 2009 Jan;11(1):45-52. doi: 10.1111/j.1463-1326.2008.00915.x. Epub 2008 Jul 17.

PMID:
18643839
[PubMed - indexed for MEDLINE]
13.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
[PubMed - indexed for MEDLINE]
14.

Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.

Levin PA, Zhang Q, Mersey JH, Lee FY, Bromberger LA, Bhushan M, Bhushan R.

Clin Ther. 2011 Jul;33(7):841-50. doi: 10.1016/j.clinthera.2011.05.091. Epub 2011 Jun 30.

PMID:
21719107
[PubMed - indexed for MEDLINE]
15.

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.

Diabetes Obes Metab. 2006 Jan;8(1):58-66.

PMID:
16367883
[PubMed - indexed for MEDLINE]
16.

Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.

Farcasiu E, Ivanyi T, Mozejko-Pastewka B, Birkus Z, Csog J, Kowalska I, Coetzer TF, Bulgurlu S, Schinzel B, Kiljanski J.

Clin Ther. 2011 Nov;33(11):1682-93. doi: 10.1016/j.clinthera.2011.10.001. Epub 2011 Oct 27.

PMID:
22036246
[PubMed - indexed for MEDLINE]
18.

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

Bretzel RG, Nuber U, Landgraf W, Owens DR, Bradley C, Linn T.

Lancet. 2008 Mar 29;371(9618):1073-84. doi: 10.1016/S0140-6736(08)60485-7. Erratum in: Lancet. 2008 Aug 30;372(9640):718.

PMID:
18374840
[PubMed - indexed for MEDLINE]
19.

Premixed insulin treatment for type 2 diabetes: analogue or human?

Garber AJ, Ligthelm R, Christiansen JS, Liebl A.

Diabetes Obes Metab. 2007 Sep;9(5):630-9. Review.

PMID:
17697056
[PubMed - indexed for MEDLINE]
20.

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.

Bode BW.

Clin Ther. 2007;29 Suppl D:S135-44. doi: 10.1016/j.clinthera.2007.12.013.

PMID:
18191065
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk